MOR GEORGE ADI

PrivateCIK: 1851069
Location

TEL AVIV, L3

MOR GEORGE ADI (Chief Executive Officer) sold 69.3% of their position (582.02K shares) of CHEMOMAB THERAPEUTICS LTD. on the open market

Open‑market sale worth $1.21M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderMOR GEORGE ADICIK 1851069
DirectorOfficer10% Owner· Chief Executive Officer
Since Mar 2021
-416.60K
Net shares
Net seller
$1.21M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
165.42K acquired · 582.02K disposed
Non-Derivative Transactions2

American Depositary Shares

Direct
S · Sale

Shares

324.77K

Price / share

$2.08

Trade value

$677.09K

% of position

50.0%
11/16/2022
649.55K324.77K

American Depositary Shares

Indirect
S · Sale

Shares

257.25K

Price / share

$2.08

Trade value

$536.31K

% of position

50.0%
11/16/2022
514.50K257.25K
Total

Net shares

582.02K

Net value

-$1.21M

Derivative Transactions2

Option to Purchase American Depositary Shares

Indirect
A · Award
Converts to

American Depositary Shares

33.73K shares

Shares

+33.73K

Strike price

0.8

Held after

33.73K

Exercisable

10/28/2016

Option to Purchase American Depositary Shares

Direct
A · Award
Converts to

American Depositary Shares

131.70K shares

Shares

+131.70K

Strike price

1.49

Held after

131.70K

Exercisable

3/15/2018
MOR GEORGE ADI — Insider Transaction (Form 4) Filed Nov 17, 2022 | Finecho